Modified Hemoglobin (GSI-1901/GSI-2001)

About Globin Solutions

Globin Solutions is a private, pre-clinical biotech developing novel antidotes for poisonings, with a lead program targeting carbon monoxide (CO). Its technology platform leverages engineered globin proteins, such as mutant neuroglobin and modified hemoglobins, which act as ultra-high-affinity scavengers to rapidly remove CO from the bloodstream. Founded in 2016 and supported by NIH STTR grants, the company aims to advance its lead candidates through preclinical development toward clinical testing, addressing a significant unmet medical need with no current antidotal therapy available.

Therapeutic Areas

Other Carbon Monoxide Poisoning Drugs